Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for FREE ACCESS to this landmark database

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Child Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Gay, C. T.
Right arrow Articles by Ryan, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gay, C. T.
Right arrow Articles by Ryan, S. G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Paroxysmal Kinesigenic Dystonia After Methylphenidate Administration

Charles T. Gay, MD

Department of Pediatrics (Neurology), The University of Texas Health Science Center at San Antonio, San Antonio, TX

Stephen G. Ryan, MD

Department of Pediatrics (Neurology), The University of Texas Health Science Center at San Antonio, San Antonio, TX

We report a patient who developed paroxysmal kinesigenic dystonia shortly after initiation of therapy with methylphenidate for presumed attention deficit-hyperactivity disorder. Attacks persisted long after methylphenidate was discontinued and responded completely to treatment with carbamazepine. Though it is possible that methylphenidate caused this syndrome in our patient, it is more likely that the stimulant triggered the onset of a genetically determined disorder. (J Child Neurol 1994;9:45-46).

Journal of Child Neurology, Vol. 9, No. 1, 45-46 (1994)
DOI: 10.1177/088307389400900110
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J Child NeurolHome page
J. L. Waugh, V. S. Miller, R. S. Chudnow, and M. M. Dowling
Juvenile Huntington Disease Exacerbated by Methylphenidate: Case Report
J Child Neurol, July 1, 2008; 23(7): 807 - 809.
[Abstract] [PDF]